Document Type

Article

Publication Date

11-2013

Keywords

whole genome sequencing, WGS, whole exome sequencing, WES, human genome

Abstract

The cost of whole genome sequencing is dropping rapidly. There has been a great deal of enthusiasm about the potential for this technological advance to transform clinical care. Given the interest and significant investment in genomics, this seems an ideal time to consider what the evidence tells us about potential benefits and harms, particularly in the context of health care policy. The scale and pace of adoption of this powerful new technology should be driven by clinical need, clinical evidence, and a commitment to put patients at the centre of health care policy.

Journal

11 PLOS Biology e1001699 (2013).

Disciplines

Genomics | Health Law

Recommended Citation

11 PLOS Biology e1001699 (2013).